Autoimmune Diseases  >>  Neo-Synephrine (phenylephrine hydrochloride ophthalmic solution)  >>  Phase N/A
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Neo-Synephrine (phenylephrine hydrochloride ophthalmic solution) / Paragon BioTeck, Bausch Health, Akorn
DENDI, NCT01097551: Endothelial Dysfunction and Diabetes

Completed
N/A
38
Europe
Trinitrin, Neosynephrine 10% collyrium, Iontophoresis with acetylcholine delivery, Dynamic Vessel Analyzer
Assistance Publique - Hôpitaux de Paris
Type 1 Diabetes Mellitus
07/11
07/11

Download Options